An ongoing dialogue on HIV/AIDS, infectious diseases,
July 26th, 2023
REPRIEVE Trial Highlights Shift in HIV Care from ID to General Medicine
The biggest news this week at the 12th IAS Conference on HIV Science here in Brisbane, Australia, was the results of REPRIEVE, a large randomized clinical trial conducted in people with HIV. It’s not a study of novel antiretroviral regimens, or of treatment or prevention of opportunistic infections, or of an HIV eradication strategy using […]
Paul E. Sax, MD
Contributing Editor
NEJM Journal Watch
Infectious Diseases
Biography | Disclosures | Summaries
Learn more about HIV and ID Observations.
NEJM Journal Watch — Recent Infectious Disease Articles- How Well Do Public and Private Healthcare Providers Manage Chlamydia and Gonorrhea?
- Delivery of Malaria Vaccine Through National Immunization Programs: Achievable and Safe
- For Coordinating Management of Opioid Use Disorder and Hepatitis C Infection, Telemedicine Works
- Innovative Pairing of Beta-Lactamase Inhibitors to Combat Multidrug-Resistant Gram-Negative Pathogens
- Ceftobiprole Joins the Beta-Lactam Squad Against MRSA Infections